Tue, March 21, 2017
Mon, March 20, 2017
Fri, March 17, 2017
Thu, March 16, 2017
Wed, March 15, 2017
Tue, March 14, 2017
Mon, March 13, 2017

Matthew Harrison Downgraded (BIIB) to Hold and Decreased Target to $305 on, Mar 16th, 2017


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. nd-decreased-target-to-305-on-mar-16th-2017.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Harrison of Morgan Stanley, Downgraded "Biogen Inc." (BIIB) to Hold and Decreased Target from $369 to $305 on, Mar 16th, 2017.

Matthew has made no other calls on BIIB in the last 4 months.



There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Alethia Young of "Cantor Fitzgerald" Initiated at Hold and Held Target at $293 on, Friday, December 16th, 2016


This is the rating of the analyst that currently disagrees with Matthew


  • Robyn Karnauskas of "Citigroup" Upgraded from Hold to Strong Buy on, Wednesday, February 8th, 2017

Publication Contributing Sources